会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明授权
    • Substituted .beta.-lactam antibiotics
    • 取代{62-内酰胺抗生素
    • US4044000A
    • 1977-08-23
    • US716606
    • 1976-08-23
    • Gary A. Koppel
    • Gary A. Koppel
    • C07D499/44C07D499/46C07D499/50C07D499/58
    • C07D501/57C07D499/44
    • 6-Alkoxylated-6-acylamidopenicillanic acids and 7-alkoxylated-7-acylamidocephalosporin acids and esters thereof, are provided by reacting a 6-acylamidopenicillanic acid ester or a 7-acylamidocephalosporin ester under anhydrous conditions at -90.degree. C. to -15.degree. C. with an alkali metal salt of a lower alkyl alcohol in the presence of an excess of the corresponding alcohol to produce, in situ, the anionic form of the antibiotic which on halogenation with a positive halogen compound, e.g. t-butyl hypochlorite, yields the compound of the invention. Compounds of the invention, e.g. 6-methoxy-6-phenoxy-acetamidopenicillanic acid and 7-methoxy-7-[2-(2-thienyl)acetamido]cephalosporanic acid are useful antibiotics.
    • 6-烷氧基化-6-酰氨基青霉烷酸和7-烷氧基化-7-酰基酰氨基头孢菌素酸及其酯通过6-酰基氨基青霉烷酸酯或7-酰基酰氨基头孢菌素酯在-90℃至-15℃的无水条件下反应来提供 用低级烷基醇的碱金属盐在过量相应的醇的存在下,原位生成阴离子形式的抗生素,其用正卤素化合物卤化,例如 叔丁基次氯酸盐,得到本发明的化合物。 本发明的化合物,例如 6-甲氧基-6-苯氧基 - 乙酰氨基青霉烷酸和7-甲氧基-7- [2-(2-噻吩基)乙酰氨基]头孢烷酸是有用的抗生素。
    • 10. 发明公开
    • Therapeutically active disulphide compounds and their use
    • Therapeutisch aktive Disulfidverbindungen und ihre Verwendung。
    • EP0064040A1
    • 1982-11-03
    • EP82850071.0
    • 1982-04-05
    • PHARMACIA AKTIEBOLAG
    • Carlsson, Jan Per ErikAxen, Rolf Erik Axel Verner
    • C07H15/24C07D499/50A61K31/43A61K31/70
    • C07D213/71C07D213/89C07D277/78C07D499/00C07H15/252
    • Therapeutically active organic compound exhibiting at least one group comprising a structure -S'-S"-R, wherein the group -S"-R is defined by R being an organic group comprised in a physiologically acceptable compound H-S"-R obtainable by the splitting of the disulfide bridge -S'-S"- in said structure, in which compound H-S"-R the sulfur atom S" is bound to a carbon atom in a heterocyclic aromatic ring in R having a configuration being such that the compound H-S"-R, while maintaining physiological acceptability, is stabilized, by tautomerism or resonance involving the sulfur atom S" bound to R, so as to be mainly excluded from reaction involving thiol disulfide exchange; S' being bound to an aliphatic carbon atom; and said compound, in addition to the group or groups comprising the structure -S'-S"-R, consisting of a residue of a therapeutically active organic base compound of non-poly-peptide structure bound to S'.
      The invention also relates to a method of modifying a therapeutically active organic compound of non-polypeptide structure by introducing a structure -S'-S"-R according to above; a method of treating diseases by administration of a compound according to the invention and also to a pharmaceutical composition containing at least one compound according to the invention.
    • 表现出至少一个包含结构-Smin -Ssec -R的基团的治疗活性有机化合物,其中基团-Ssec -R由R是由生理学上可接受的化合物HS sec -R中包含的有机基团 所述结构中的二硫键-Smin -Ssec的分解,其中化合物HSsec-R硫原子S sec与R中的杂环芳环中的碳原子结合,其结构使得化合物HS 秒-R,同时保持生理可接受性,通过互变异构或包含与R结合的硫原子的共振的共振来稳定,以便主要排除在涉及硫醇二硫化物交换的反应之外; S min与脂肪族碳原子结合; 和所述化合物,除了包含结构-Smin -Ssec-R的基团或基团,由与S min结合的非多肽结构的治疗活性有机碱性化合物的残基组成。 本发明还涉及通过引入上述结构-Smin -Ssec -R来修饰非多肽结构的治疗活性有机化合物的方法; 通过施用根据本发明的化合物治疗疾病的方法,还涉及含有至少一种本发明化合物的药物组合物。